Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 32

1.

Patient-Reported Outcomes Over 5 Years After Whole- or Partial-Breast Radiotherapy: Longitudinal Analysis of the IMPORT LOW (CRUK/06/003) Phase III Randomized Controlled Trial.

Bhattacharya IS, Haviland JS, Kirby AM, Kirwan CC, Hopwood P, Yarnold JR, Bliss JM, Coles CE; IMPORT Trialists.

J Clin Oncol. 2019 Feb 1;37(4):305-317. doi: 10.1200/JCO.18.00982. Epub 2018 Dec 11.

2.

The IMPORT LOW Trial: Collaborative Research Accelerates Practice Change in Breast Radiotherapy.

Kirby AM, Bhattacharya IS, Wilcox M, Haviland JS.

Clin Oncol (R Coll Radiol). 2019 Jan;31(1):5-8. doi: 10.1016/j.clon.2018.08.007. Epub 2018 Sep 17. No abstract available.

PMID:
30236641
3.

Patient advocate involvement in the design and conduct of breast cancer clinical trials requiring the collection of multiple biopsies.

Batten LM, Bhattacharya IS, Moretti L, Haviland JS, Emson MA, Miller SE, Jefford M, MacKenzie M, Wilcox M, Hyslop M, Todd R, Snowdon CF, Bliss JM.

Res Involv Engagem. 2018 Jul 16;4:22. doi: 10.1186/s40900-018-0108-0. eCollection 2018.

4.

Women's Free-text Comments on their Quality of Life: An Exploratory Analysis from the UK Standardisation of Breast Radiotherapy (START) Trials for Early Breast Cancer.

Mills J, Haviland JS, Moynihan C, Bliss JM, Hopwood P; START Trial Management Group.

Clin Oncol (R Coll Radiol). 2018 Jul;30(7):433-441. doi: 10.1016/j.clon.2018.03.007. Epub 2018 Apr 10.

5.

Targeted radiotherapy for early breast cancer - Authors' reply.

Coles CE, Haviland JS, Kirby AM, Titley J, Wilcox M, Bliss JM, Yarnold JR.

Lancet. 2018 Jan 6;391(10115):27-28. doi: 10.1016/S0140-6736(17)33317-2. No abstract available.

PMID:
29323651
6.

Late normal tissue effects in the arm and shoulder following lymphatic radiotherapy: Results from the UK START (Standardisation of Breast Radiotherapy) trials.

Haviland JS, Mannino M, Griffin C, Porta N, Sydenham M, Bliss JM, Yarnold JR; START Trialists' Group.

Radiother Oncol. 2018 Jan;126(1):155-162. doi: 10.1016/j.radonc.2017.10.033. Epub 2017 Nov 15.

7.

Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial.

Coles CE, Griffin CL, Kirby AM, Titley J, Agrawal RK, Alhasso A, Bhattacharya IS, Brunt AM, Ciurlionis L, Chan C, Donovan EM, Emson MA, Harnett AN, Haviland JS, Hopwood P, Jefford ML, Kaggwa R, Sawyer EJ, Syndikus I, Tsang YM, Wheatley DA, Wilcox M, Yarnold JR, Bliss JM; IMPORT Trialists.

Lancet. 2017 Sep 9;390(10099):1048-1060. doi: 10.1016/S0140-6736(17)31145-5. Epub 2017 Aug 2.

8.

The UK HeartSpare Study (Stage II): Multicentre Evaluation of a Voluntary Breath-hold Technique in Patients Receiving Breast Radiotherapy.

Bartlett FR, Donovan EM, McNair HA, Corsini LA, Colgan RM, Evans PM, Maynard L, Griffin C, Haviland JS, Yarnold JR, Kirby AM.

Clin Oncol (R Coll Radiol). 2017 Mar;29(3):e51-e56. doi: 10.1016/j.clon.2016.11.005. Epub 2016 Nov 24.

PMID:
27890346
9.

Prolongation of overall treatment time as a cause of treatment failure in early breast cancer: An analysis of the UK START (Standardisation of Breast Radiotherapy) trials of radiotherapy fractionation.

Haviland JS, Bentzen SM, Bliss JM, Yarnold JR; START Trial Management Group.

Radiother Oncol. 2016 Dec;121(3):420-423. doi: 10.1016/j.radonc.2016.08.027. Epub 2016 Sep 22.

10.

Does breast composition influence late adverse effects in breast radiotherapy?

Juneja P, Bonora M, Haviland JS, Harris E, Evans P, Somaiah N.

Breast. 2016 Apr;26:25-30. doi: 10.1016/j.breast.2015.12.004. Epub 2016 Jan 5.

11.

Do Patient-reported Outcome Measures Agree with Clinical and Photographic Assessments of Normal Tissue Effects after Breast Radiotherapy? The Experience of the Standardisation of Breast Radiotherapy (START) Trials in Early Breast Cancer.

Haviland JS, Hopwood P, Mills J, Sydenham M, Bliss JM, Yarnold JR; START Trialists' Group.

Clin Oncol (R Coll Radiol). 2016 Jun;28(6):345-53. doi: 10.1016/j.clon.2016.01.011. Epub 2016 Feb 8.

12.

A multicentre study of the evidence for customized margins in photon breast boost radiotherapy.

Harris EJ, Mukesh MB, Donovan EM, Kirby AM, Haviland JS, Jena R, Yarnold J, Baker A, Dean J, Eagle S, Mayles H, Griffin C, Perry R, Poynter A, Coles CE, Evans PM; IMPORT high trialists.

Br J Radiol. 2016;89(1058):20150603. doi: 10.1259/bjr.20150603. Epub 2015 Nov 20.

13.

In Regard to Vaidya et al.

Haviland JS, Bliss JM, Bentzen SM, Cuzick J.

Int J Radiat Oncol Biol Phys. 2015 Aug 1;92(5):954-955. doi: 10.1016/j.ijrobp.2015.05.026. Epub 2015 Jul 14. No abstract available.

PMID:
26194664
14.

The UK HeartSpare Study (Stage IB): randomised comparison of a voluntary breath-hold technique and prone radiotherapy after breast conserving surgery.

Bartlett FR, Colgan RM, Donovan EM, McNair HA, Carr K, Evans PM, Griffin C, Locke I, Haviland JS, Yarnold JR, Kirby AM.

Radiother Oncol. 2015 Jan;114(1):66-72. doi: 10.1016/j.radonc.2014.11.018. Epub 2014 Nov 26.

PMID:
25739317
15.

A multicentre observational study evaluating image-guided radiotherapy for more accurate partial-breast intensity-modulated radiotherapy: comparison with standard imaging technique.

Harris EJ, Mukesh M, Jena R, Baker A, Bartelink H, Brooks C, Dean J, Donovan EM, Collette S, Eagle S, Fenwick JD, Graham PH, Haviland JS, Kirby AM, Mayles H, Mitchell RA, Perry R, Poortmans P, Poynter A, Shentall G, Titley J, Thompson A, Yarnold JR, Coles CE, Evans PM; on behalf of the IMPORT Trials Management Group.

Southampton (UK): NIHR Journals Library; 2014 Nov.

16.

The IMPORT HIGH image-guided radiotherapy study: a model for assessing image-guided radiotherapy.

Donovan EM, Harris EJ, Mukesh MB, Haviland JS, Titley J, Griffin C, Coles CE, Evans PM; IMPORT Trials Management Group.

Clin Oncol (R Coll Radiol). 2015 Jan;27(1):3-5. doi: 10.1016/j.clon.2014.09.012. Epub 2014 Oct 16. No abstract available.

PMID:
25445551
17.

Voluntary breath-hold technique for reducing heart dose in left breast radiotherapy.

Bartlett FR, Colgan RM, Donovan EM, Carr K, Landeg S, Clements N, McNair HA, Locke I, Evans PM, Haviland JS, Yarnold JR, Kirby AM.

J Vis Exp. 2014 Jul 3;(89). doi: 10.3791/51578.

18.

Radiotherapy for breast cancer, the TARGIT-A trial.

Haviland JS, A'Hern R, Bentzen SM, Whelan T, Bliss JM.

Lancet. 2014 May 17;383(9930):1716-7. doi: 10.1016/S0140-6736(14)60826-6. No abstract available.

PMID:
24835609
19.

Late effects of breast radiotherapy.

Haviland JS, Bliss JM, Sydenham M, Yarnold JR.

Lancet. 2014 Apr 19;383(9926):1383-4. doi: 10.1016/S0140-6736(14)60681-4. No abstract available.

PMID:
24759249
20.

The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials.

Haviland JS, Owen JR, Dewar JA, Agrawal RK, Barrett J, Barrett-Lee PJ, Dobbs HJ, Hopwood P, Lawton PA, Magee BJ, Mills J, Simmons S, Sydenham MA, Venables K, Bliss JM, Yarnold JR; START Trialists' Group.

Lancet Oncol. 2013 Oct;14(11):1086-1094. doi: 10.1016/S1470-2045(13)70386-3. Epub 2013 Sep 19.

PMID:
24055415

Supplemental Content

Loading ...
Support Center